SivriFTürközIŞencanMİçenYKAksoyFCeyhanBÖ.Does COVID-19 cause non-dipper hypertension?Angiology. 2025;76(3):257-263. doi:10.1177/00033197231209584
2.
GrassiGSeravalleGManciaG.Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications. Eur J Clin Invest. 2015;45(12):1367-1375. doi:10.1111/eci.12556
3.
ParatiGPengoMFAvolioA, et al. Nocturnal blood pressure: pathophysiology, measurement and clinical implications. Position paper of the European Society of Hypertension. J Hypertens. 2025;43(8):1296-1318. doi:10.1097/HJH.0000000000003603
4.
ÖzyaşarMMemioğluT.Comparative analysis of systemic inflammatory biomarkers on dipper and non-dipper hypertension phenotypes. Medicine (Baltimore). 2025;104(19):e42371. doi:10.1097/MD.0000000000042371
5.
KarioKShinJChenCHet al. Ambulatory blood pressure monitoring in hypertension: current concepts and clinical applications. J Clin Hypertens (Greenwich). 2019;21(10):1505-1517. doi:10.1111/jch.13636.
